These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Familial Parkinson's disease: clinical and genetic analysis of four Basque families. Paisàn-Ruìz C; Sàenz A; Lòpez de Munain A; Martì I; Martìnez Gil A; Martì-Massò JF; Pèrez-Tur J Ann Neurol; 2005 Mar; 57(3):365-72. PubMed ID: 15732106 [TBL] [Abstract][Full Text] [Related]
4. Generation of a human iPSC line (CIBi014-A) from a patient with Parkinson's disease carrying a novel heterozygotic PARK8 (LRRK2) mutation. Li L; Si X; Yang J; Lei M; Liu H; Ruan J; Fu H; Li W; Yang H; Lei X; Sang H Stem Cell Res; 2023 Feb; 66():102995. PubMed ID: 36528012 [TBL] [Abstract][Full Text] [Related]
5. Mutations in LRRK2 cause autosomal-dominant parkinsonism with pleomorphic pathology. Zimprich A; Biskup S; Leitner P; Lichtner P; Farrer M; Lincoln S; Kachergus J; Hulihan M; Uitti RJ; Calne DB; Stoessl AJ; Pfeiffer RF; Patenge N; Carbajal IC; Vieregge P; Asmus F; Müller-Myhsok B; Dickson DW; Meitinger T; Strom TM; Wszolek ZK; Gasser T Neuron; 2004 Nov; 44(4):601-7. PubMed ID: 15541309 [TBL] [Abstract][Full Text] [Related]
6. An LRRK2 mutation as a cause for the parkinsonism in the original PARK8 family. Funayama M; Hasegawa K; Ohta E; Kawashima N; Komiyama M; Kowa H; Tsuji S; Obata F Ann Neurol; 2005 Jun; 57(6):918-21. PubMed ID: 15880653 [TBL] [Abstract][Full Text] [Related]
8. α-Synuclein, leucine-rich repeat kinase-2, and manganese in the pathogenesis of Parkinson disease. Covy JP; Giasson BI Neurotoxicology; 2011 Oct; 32(5):622-9. PubMed ID: 21238487 [TBL] [Abstract][Full Text] [Related]
9. Founder mutation p.R1441C in the leucine-rich repeat kinase 2 gene in Belgian Parkinson's disease patients. Nuytemans K; Rademakers R; Theuns J; Pals P; Engelborghs S; Pickut B; de Pooter T; Peeters K; Mattheijssens M; Van den Broeck M; Cras P; De Deyn PP; van Broeckhoven C Eur J Hum Genet; 2008 Apr; 16(4):471-9. PubMed ID: 18197194 [TBL] [Abstract][Full Text] [Related]
10. Clinical and pathologic features of families with LRRK2-associated Parkinson's disease. Whaley NR; Uitti RJ; Dickson DW; Farrer MJ; Wszolek ZK J Neural Transm Suppl; 2006; (70):221-9. PubMed ID: 17017533 [TBL] [Abstract][Full Text] [Related]
11. LRRK2 R1441G in Spanish patients with Parkinson's disease. Mata IF; Taylor JP; Kachergus J; Hulihan M; Huerta C; Lahoz C; Blazquez M; Guisasola LM; Salvador C; Ribacoba R; Martinez C; Farrer M; Alvarez V Neurosci Lett; 2005 Jul; 382(3):309-11. PubMed ID: 15925109 [TBL] [Abstract][Full Text] [Related]
12. Genetics of Parkinson's disease. Morris HR Ann Med; 2005; 37(2):86-96. PubMed ID: 16026116 [TBL] [Abstract][Full Text] [Related]
13. Neuropathology of Parkinson's disease with the R1441G mutation in LRRK2. Martí-Massó JF; Ruiz-Martínez J; Bolaño MJ; Ruiz I; Gorostidi A; Moreno F; Ferrer I; López de Munain A Mov Disord; 2009 Oct; 24(13):1998-2001. PubMed ID: 19735093 [TBL] [Abstract][Full Text] [Related]
14. What genetics tells us about the causes and mechanisms of Parkinson's disease. Corti O; Lesage S; Brice A Physiol Rev; 2011 Oct; 91(4):1161-218. PubMed ID: 22013209 [TBL] [Abstract][Full Text] [Related]
15. How genetics research in Parkinson's disease is enhancing understanding of the common idiopathic forms of the disease. Cookson MR; Xiromerisiou G; Singleton A Curr Opin Neurol; 2005 Dec; 18(6):706-11. PubMed ID: 16280683 [TBL] [Abstract][Full Text] [Related]
16. [A PARK8 form of Parkinson's disease: a mutational analysis of the LRRK2 gene in Russian population]. Shadrina MI; Illarioshkin SN; Bagyeva GKh; Bespalova EV; Zagorodskaia TB; Slominskiĭ PA; Markova ED; Kliushnikov SA; Limborskaia SA; Ivanova-Smolenskaia IA Zh Nevrol Psikhiatr Im S S Korsakova; 2007; 107(3):46-50. PubMed ID: 18379513 [TBL] [Abstract][Full Text] [Related]
17. Genetics of Parkinson's disease. Bonifati V Minerva Med; 2005 Jun; 96(3):175-86. PubMed ID: 16175160 [TBL] [Abstract][Full Text] [Related]
18. Parkinson's disease due to the R1441G mutation in Dardarin: a founder effect in the Basques. Simón-Sánchez J; Martí-Massó JF; Sánchez-Mut JV; Paisán-Ruiz C; Martínez-Gil A; Ruiz-Martínez J; Sáenz A; Singleton AB; López de Munain A; Pérez-Tur J Mov Disord; 2006 Nov; 21(11):1954-9. PubMed ID: 16991141 [TBL] [Abstract][Full Text] [Related]
20. Clinical features of LRRK2-associated Parkinson's disease in central Norway. Aasly JO; Toft M; Fernandez-Mata I; Kachergus J; Hulihan M; White LR; Farrer M Ann Neurol; 2005 May; 57(5):762-5. PubMed ID: 15852371 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]